Abstract:Background: Trichothiodystrophy-1 (TTD1) is an autosomal-recessive disease and caused by mutations in ERCC2, a gene coding for a subunit of the TFIIH transcription and nucleotide-excision repair (NER) factor. In almost half of these patients infectious susceptibility has been reported but the underlying molecular mechanism leading to immunodeficiency is largely unknown. Objective: The aim of this study was to perform extended molecular and immunological phenotyping in patients suffering from TTD1. Methods: Cellular immune phenotype was investigated using multicolor flow cytometry. DNA repair efficiency was evaluated in UV-irradiation assays. Furthermore, early BCR activation events and proliferation of TTD1 lymphocytes following DNA damage induction was tested. In addition, we performed differential gene expression analysis in peripheral lymphocytes of TTD1 patients. Results: We investigated three unrelated TTD1 patients who presented with recurrent infections early in life of whom two harbored novel ERCC2 mutations and the third patient is a carrier of previously described pathogenic ERCC2 mutations. Hypogammaglobulinemia and decreased antibody responses following vaccination were found. TTD1 B-cells showed accumulation of γ-H2AX levels, decreased proliferation activity and reduced cell viability following UV-irradiation. mRNA sequencing analysis revealed significantly downregulated genes needed for B-cell development and activation. Analysis of B-cell subpopulations showed low numbers of naïve and transitional B-cells in TTD1 patients, indicating abnormal B-cell differentiation in vivo. Conclusion: In summary, our analyses confirmed the pathogenicity of novel ERCC2 mutations and show that ERCC2 deficiency is associated with antibody deficiency most likely due to altered B-cell differentiation resulting from impaired BCR-mediated B-cell activation and activation-induced gene transcription.

Mutations in topoisomerase IIβ result in a B cell immunodeficiency

Topoisomerase II deficiency leads to a postreplicative structural shift in all Saccharomyces cerevisiae chromosomes

Developing T lymphocytes are uniquely sensitive to a lack of topoisomerase III alpha.

Topoisomerase IIb binding underlies frequently mutated elements in cancer genomes

B-cell biology and development

Germline TET2 loss of function causes childhood immunodeficiency and lymphoma

Impaired B-cell function in ERCC2 deficiency

Human DNA Topoisomerases IIα and IIβ Can Functionally Substitute for Yeast TOP2 in Chromosome Segregation and Recombination

Pat1: a Topoisomerase II-associated Protein Required for Faithful Chromosome Transmission in Saccharomyces Cerevisiae.

Isolation of Cdna Clones Encoding the Β Isozyme of Human DNA Topoisomerase II and Localisation of the Gene to Chromosome 3P24

Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance

Mutual Inhibition Between Prkd2 and Bcl6 Controls T Follicular Helper Cell Differentiation

A Spontaneous H2-Aa Point Mutation Impairs MHC II Synthesis and CD4+ T-Cell Development in Mice

Inhibition of topoisomerase IIA (Top2α) induces telomeric DNA damage and T cell dysfunction during chronic viral infection.

Phosphorylation of Serine 1106 in the Catalytic Domain of Topoisomerase IIα Regulates Enzymatic Activity and Drug Sensitivity

The mammalian SKIV2L RNA exosome is essential for early B cell development

Dual T Cell– and B Cell–intrinsic Deficiency in Humans with Biallelic RLTPR Mutations

AKT2 Deficiency Impairs Formation of the BCR Signalosome

A Nonsense Mutation in IKBKB Causes Combined Immunodeficiency.

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function

An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence